113 related articles for article (PubMed ID: 25297779)
1. [Systematic approach to organ-specific complications after allogeneic hematopoietic cell transplantation].
Ichinohe T
Rinsho Ketsueki; 2014 Oct; 55(10):2125-35. PubMed ID: 25297779
[No Abstract] [Full Text] [Related]
2. [Management of CKD-MBD in kidney transplant patients].
Isaka Y; Fujii N; Rakugi H
Nihon Jinzo Gakkai Shi; 2013; 55(2):153-8. PubMed ID: 23631302
[No Abstract] [Full Text] [Related]
3. [Renal insufficiency after allogeneic stem cell transplantation in children].
Kato I; Umeda K; Matsubara H; Hiramatsu H; Watanabe K; Adachi S; Nakahata T
Rinsho Ketsueki; 2008 Nov; 49(11):1530-5. PubMed ID: 19047783
[TBL] [Abstract][Full Text] [Related]
4. Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
Hautmann AH; Elad S; Lawitschka A; Greinix H; Bertz H; Halter J; Faraci M; Hofbauer LC; Lee S; Wolff D; Holler E
Transpl Int; 2011 Sep; 24(9):867-79. PubMed ID: 21557780
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular complications in long-term survivors after allogeneic hematopoietic stem cell transplantation.
Rovó A; Tichelli A;
Semin Hematol; 2012 Jan; 49(1):25-34. PubMed ID: 22221782
[TBL] [Abstract][Full Text] [Related]
6. Early central nervous system complications after reduced-intensity stem cell transplantation.
Kishi Y; Miyakoshi S; Kami M; Ikeda M; Katayama Y; Murashige N; Kusumi E; Yuji K; Kobayashi K; Kato D; Hamaki T; Matsumura T; Kim SW; Morinaga S; Mori S; Kanemaru M; Hayashi T; Takaue Y; Taniguchi S;
Biol Blood Marrow Transplant; 2004 Aug; 10(8):561-8. PubMed ID: 15282534
[TBL] [Abstract][Full Text] [Related]
7. [Factors for the development and progression of cardiorenal complications in women].
Chicherina EN; Padyganova AV
Ter Arkh; 2013; 85(6):85-9. PubMed ID: 23866604
[TBL] [Abstract][Full Text] [Related]
8. Abdominal complications following hematopoietic stem cell transplantation.
del Campo L; León NG; Palacios DC; Lagana C; Tagarro D
Radiographics; 2014; 34(2):396-412. PubMed ID: 24617687
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment.
Hingorani S
J Am Soc Nephrol; 2006 Jul; 17(7):1995-2005. PubMed ID: 16723390
[TBL] [Abstract][Full Text] [Related]
10. [Selection of fluid treatment based on pathophysiology].
Nakayama Y; Tomita K
Nihon Jinzo Gakkai Shi; 2008; 50(2):100-9. PubMed ID: 18421965
[No Abstract] [Full Text] [Related]
11. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
[TBL] [Abstract][Full Text] [Related]
12. GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation.
Sakellari I; Barbouti A; Bamichas G; Mallouri D; Kaloyannidis P; Fragidis S; Batsis I; Apostolou C; Karpouza A; Yannaki E; Smias C; Sombolos K; Anagnostopoulos A
Bone Marrow Transplant; 2013 Oct; 48(10):1329-34. PubMed ID: 23584436
[TBL] [Abstract][Full Text] [Related]
13. Renal and pulmonary late effects of cancer therapy.
Skinner R; Kaplan R; Nathan PC
Semin Oncol; 2013 Dec; 40(6):757-73. PubMed ID: 24331195
[TBL] [Abstract][Full Text] [Related]
14. Neurological complications after stem cell transplantation in childhood.
Iguchi A; Kobayashi R; Yoshida M; Kaneda M; Watanabe N; Cho Y; Arioka H; Naito H; Shikano T; Ishikawa Y
Bone Marrow Transplant; 1999 Sep; 24(6):647-52. PubMed ID: 10490731
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease after hematopoietic stem cell transplantation.
Cohen EP; Pais P; Moulder JE
Semin Nephrol; 2010 Nov; 30(6):627-34. PubMed ID: 21146127
[TBL] [Abstract][Full Text] [Related]
16. Rethinking primary prevention of atherosclerosis-related diseases.
Napoli C; Lerman LO; de Nigris F; Gossl M; Balestrieri ML; Lerman A
Circulation; 2006 Dec; 114(23):2517-27. PubMed ID: 17146003
[No Abstract] [Full Text] [Related]
17. Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
Manns BJ; Hodsman A; Zimmerman DL; Mendelssohn DC; Soroka SD; Chan C; Jindal K; Klarenbach S
Am J Kidney Dis; 2010 May; 55(5):800-12. PubMed ID: 20438984
[No Abstract] [Full Text] [Related]
18. [Diabetic nephropathy: new insights into diagnosis, prevention and treatment].
Rheinberger M; Böger CA
Dtsch Med Wochenschr; 2014 Apr; 139(14):704-6. PubMed ID: 24668430
[No Abstract] [Full Text] [Related]
19. [Effect of statins on renal function].
Kasahara M
Nihon Jinzo Gakkai Shi; 2013; 55(7):1295-300. PubMed ID: 24288966
[No Abstract] [Full Text] [Related]
20. Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation.
Yao S; Smiley SL; West K; Lamonica D; Battiwalla M; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2010 Aug; 16(8):1130-7. PubMed ID: 20188201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
